07 November 2023
: Case report
Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report
Unusual or unexpected effect of treatment, Unexpected drug reaction
Jie Li1E, Junwei Liu2BC, Guqin Zhang3B, Weidong Hu2G, Xianguo Wang2B*, Jun Liu2ADOI: 10.12659/AJCR.942150
Am J Case Rep 2023; 24:e942150
Figure 3. Evaluation after the surgery. (A–C) CT image of chest after surgery. (D) HE stain of right upper lung showed interstitial fibrous tissue proliferation accompanied by chronic inflammatory cell infiltration, hemosiderin deposition, and aggregation of tissue cells within the pulmonary alveoli. No residual tumor was observed.






